HUM Stock Analysis — AI Buy/Sell Signals & Forecast
Real-time AI-powered analysis for HUM with price targets, technical indicators (RSI, MACD, SMA), institutional money flow, and news-based signals.
Unlock Full Pro Analysis
Real-time alerts, price targets, institutional flow & more — one-time $19.95.
HUM · Humana Inc.
Free summary — full analysis below.
Humana Inc.
Pre-Market & After Hours is Pro Only
Upgrade to unlock this and all premium features
Oct 8, 07:14 AM
Confidence Score is Pro Only
Upgrade to unlock this and all premium features
Optimal Buy & Sell Zones is Pro Only
Upgrade to unlock this and all premium features
Strong Uptrend — Price above SMA50 & SMA200, Golden Cross
Total Conviction Scorecard is Pro Only
Upgrade to unlock this and all premium features
Optimal Buy & Sell Zones is Pro Only
Upgrade to unlock this and all premium features
$-32.37 (-7.5%) from high
Day's Range: $394.81 – $410.00
+$233.40 (+143.1%) above low
▲ Above — short-term uptrend (bullish)
▲ Above — long-term uptrend (bullish)
📈 1.5x avg — more traders active than usual
📈 Elevated — more buyers/sellers active than usual
RSI, MACD & SMA based on daily closes — update at market close. Live price shown separately.
Institutional Money Flow is Pro Only
Upgrade to unlock this and all premium features
Phantom Flow is Pro Only
Upgrade to unlock this and all premium features
Smart Money Flow Index is Pro Only
Upgrade to unlock this and all premium features
Risk Score is Pro Only
Upgrade to unlock this and all premium features
Humana faces significant headwinds from Medicare star rating pressures and elevated operational costs in the Medicare Advantage sector. While analyst upgrades suggest a potential turnaround, the stock remains in a volatile period that warrants waiting for further evidence of sustained earnings improvement.
Latest News & Market Impact
Humana Faces Medicare ‘Stars’ Rating. The Result Will Test the Stock.
Suze Orman Warned 390,000 People Their Medicare Plans Are Shutting Down, Then CNBC Called the Same Stock a Turnaround
Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls
Is Humana (HUM) Stock Priced For Its Stronger Earnings Outlook?
Cantor Fitzgerald Upgrades Humana to Overweight, Price Target is $460
Disclaimer: This analysis is AI-generated and should not be considered financial advice. Always consult a qualified financial advisor before making investment decisions.
HUM Stock Analysis — Frequently Asked Questions
Is HUM a buy or sell right now?▾
Our AI engine analyzes HUM across technicals (RSI, MACD, SMA50/200), institutional money flow (OBV, SEC 13D/13G filings), news sentiment, and price action to produce a real-time buy/sell signal with a confidence score. The recommendation updates every time the analysis runs.
What is the price target for HUM?▾
The analysis calculates optimal entry and exit price targets for HUM using support/resistance levels, moving-average structure, and momentum. These levels are dynamic and recompute as new market data arrives.
What do the RSI and MACD signals say about HUM?▾
RSI measures whether HUM is overbought or oversold; MACD shows momentum and trend shifts. A bullish MACD crossover with RSI below 70 often signals continued upside, while divergence can warn of a reversal.
Are institutions buying HUM?▾
We track institutional positioning in HUM through On-Balance Volume (OBV) money flow and SEC Schedule 13D/13G filings — the same disclosures activist investors and large funds must file. Rising OBV plus new 13D filings typically indicate smart-money accumulation.
What are the main risks of investing in HUM?▾
Key risks for HUM include valuation compression, sector rotation, earnings volatility, and macro factors such as rates and inflation. The analysis grades risk from very low to very high based on volatility, drawdown history, and beta.
How accurate is the HUM AI analysis?▾
The HUM analysis combines real-time market data, technical indicators, institutional flow, and news-based sentiment. It is a decision-support tool, not financial advice — always do your own research and consider your risk tolerance before investing.
Market Intelligence provides AI-powered stock & ETF analysis for informational purposes only and does not constitute financial advice.